A high incidence of MSH6 mutations in Amsterdam criteria Il-negative families tested in a diagnostic setting

Ramsoekh, D.; Wagner, A.; van Leerdam, M. E.; Dinjens, W. N. M.; Steyerberg, E. W.; Halley, D. J. J.; Kuipers, E. J.; Dooijes, D.
November 2008
Gut;Nov2008, Vol. 57 Issue 11, p1539
Academic Journal
Background and aims: In Lynch syndrome, the clinical phenotype in MSH6 mutation families differs from that in MLHI and MSH2 families. Therefore, MSH6 mutation families are less likely to fulfil diagnostic criteria such as the Amsterdam II criteria (AC II) and the revised Bethesda guidelines (rBG), and will be underdiagnosed. The aim of the present study was to evaluate the contribution of MSH6 gene mutations in families that were analysed for Lynch syndrome in a diagnostic setting. Methods: Families that had molecular analysis for Lynch syndrome were included in this study. Complete molecular screening of the MLH1, MSH2 and MSH6 genes was performed in all families. Microsatellite instability (MSI) and immunohistochemical (IHC) analysis was performed in almost all families. Clinical data were collected from medical records and family pedigrees. Results: A total of 108 families were included. MSI and IRC analysis was performed in 97 families, and in 40 an MSI-high phenotype with absent protein expression was found. Germline mutation analysis detected mutations in 23 families (7 MLHJ, 4 MSH2 and 12 MSH6). The majority of MSH6 families were AC II negative, but fulfilled the rBG. Conclusions: There is a high incidence of MSH6 mutations in families tested for Lynch syndrome in a diagnostic setting. Many of these families remain underdiagnosed using the AC II. The rBG are more useful to select these families for further analysis. However, to optimise the detection of MSH6 families, MSI and IHC analysis should also be performed in families with clustering of late-onset endometrial carcinoma.


Related Articles

  • HNPCC: Six new pathogenic mutations. Kunstmann, Erdmute; Vieland, Judith; Brasch, Frank E.; Hahn, Stephan A.; Epplen, Joerg T.; Schulmann, Karsten; Schmiegel, Wolff // BMC Medical Genetics;2004, Vol. 5, p16 

    Background: Hereditary non-polyposis colorectal cancer (HNPCC) is an autosomal dominant disease with a high risk for colorectal and endometrial cancer caused by germline mutations in DNA mismatch-repair genes (MMR). HNPCC accounts for approximately 2 to 5% of all colorectal cancers. Here we...

  • Very low prevalence of germline MSH6 mutations in hereditary non-polyposis colorectal cancer suspected patients with colorectal cancer without microsatellite instability. Kets, C. M.; van Krieken, J. H. J. M.; Hebeda, K. M.; Wezenberg, S. J.; Goossens, M.; Brunner, H. G.; Ligtenberg, M. J. L.; Hoogerbrugge, N. // British Journal of Cancer;12/18/2006, Vol. 95 Issue 12, p1678 

    Hereditary non-polyposis colorectal cancer (HNPCC) is caused by mutations in one of the mismatch repair genes MLH1, MSH2, MSH6, or PMS2 and results in high-level microsatellite instability (MSI-high) in tumours of HNPCC patients. The MSI test is considered reliable for indicating mutations in...

  • Correlation of tumour BRAF mutations and MLH1 methylation with germline mismatch repair (MMR) gene mutation status: a literature review assessing utility of tumour features forMMRvariant classification. Parsons, Michael T.; Buchanan, Daniel D.; Thompson, Bryony; Young, Joanne P.; Spurdle, Amanda B. // Journal of Medical Genetics;Mar2012, Vol. 49 Issue 3, p151 

    Colorectal cancer (CRC) that demonstrates microsatellite instability (MSI) is caused by either germline mismatch repair (MMR) gene mutations, or 'sporadic' somatic tumour MLH1 promoter methylation. MLH1 promoter methylation is reportedly correlated with tumour BRAF V600E mutation status. No...

  • A mononucleotide markers panel to identify hMLH1/hMSH2 germline mutations. Pedroni, M.; Roncari, B.; Maffei, S.; Losi, L.; Scarselli, A.; Di Gregorio, C.; Marino, M.; Roncucci, L.; Benatti, P.; Ponti, G.; Rossi, G.; Menigatti, M.; Viel, A.; Genuardi, M.; de Leon, M. Ponz // Disease Markers;2007, Vol. 23 Issue 3, p179 

    Hereditary NonPolyposis Colorectal Cancer (Lynch syndrome) is an autosomal dominant disease caused by germline mutations in a class of genes deputed to maintain genomic integrity during cell replication, mutations result in a generalized genomic instability, particularly evident at...

  • Phenotypic heterogeneity in hereditary non-polyposis colorectal cancer: identical germline mutations associated with variable tumour morphology and immunohistochemical expression. Halvarsson, Britta; Müller, Wolfram; Planck, Maria; Benoni, Anna Clara; Mangell, Peter; Ottosson, Johan; Hallén, Magnus; Isinger, Anna; Nilbert, Mef // Journal of Clinical Pathology;Jul2007, Vol. 60 Issue 7, p781 

    Background: Hereditary non-polyposis colorectal cancer (HNPCC) is associated with high risks for colorectal and endometrial cancer, young age at onset and an increased risk of multiple primary tumours. Colorectal cancer in HNPCC is characterised by poor tumour differentiation, an expanding...

  • Genomic alteration in hereditary colorectal patients without mutations in mismatch repair genes. Villacis, Rolando A. R.; Santos, Érika M. M.; Rossi, Benedito M.; Carraro, Dirce M.; Kowalski, Luiz P.; Rogatto, Silvia R. // BMC Proceedings;2013, Vol. 7 Issue Suppl 2, p1 

    The article offers information on the common hereditary syndrome of colorectal cancer (CRC) named Lynch Syndrome (LS). It mentions that the syndrome has caused by mutations in mismatch repair (MMR) genes. It also discusses the findings of Amsterdam criteria used for evaluating the germline...

  • The G67E mutation in hMLH1 is associated with an unusual presentation of Lynch syndrome. Clyne, M.; Offman, J.; Shanley, S.; Virgo, J. D.; Radulovic, M.; Wang, Y.; Ardern-Jones, A.; Eeles, R.; Hoffmann, E.; Yu, V. P. C. C. // British Journal of Cancer;1/27/2009, Vol. 100 Issue 2, p376 

    Germline mutations in the mismatch repair (MMR) genes are associated with Lynch syndrome, also known as hereditary non-polyposis colorectal cancer (HNPCC) syndrome. Here, we characterise a variant of hMLH1 that confers a loss-of-function MMR phenotype. The mutation changes the highly conserved...

  • mutHLS.  // Encyclopedic Reference of Cancer;2001, p609 

    An encyclopedia entry for mutHLS is presented. It refers to the mismatch repair system in the bacterium Escherichia coli. Five human proteins with homology to the mut S component and four homologues to mut L have been identified. Germline mutations in some of these genes predispose to hereditary...

  • Risk Factors Associated with Colorectal Cancer in a Subset of Patients with Mutations in MLH1 and MSH2 in Taiwan Fulfilling the Amsterdam II Criteria for Lynch Syndrome. Kamiza, Abram Bunya; Hsieh, Ling-Ling; Tang, Reiping; Chien, Huei-Tzu; Lai, Chih-Hsiung; Chiu, Li-Ling; Lo, Tsai-Ping; Hung, Kuan-Yi; Wang, Chun-Yi; You, Jeng-Fu; Hsiung, Chao A.; Yeh, Chih-Ching // PLoS ONE;Jun2015, Vol. 10 Issue 6, p1 

    Background and Aim: Lynch syndrome, caused by germline mutations in mismatch repair genes, is a predisposing factor for colorectal cancer (CRC). This retrospective cohort study investigated the risk factors associated with the development of CRC in patients with MLH1 and MSH2 germline...


Read the Article


Sign out of this library

Other Topics